The short answer
Avoid adding ephedrine-alkaloid supplements to your treatment plan. Ephedra has serious standalone risks, although a specific interaction with aripiprazole lauroxil is not established.
What this answer covers
Ephedra sinica and ephedrine-alkaloid-containing products; amount and other stimulant ingredients matter.
- Supplement or preparation
- Ephedra sinica
- Medication ingredient
- aripiprazole lauroxil
The supplement has risks of its own
NCCIH links ephedra to serious cardiovascular and psychiatric problems. Dietary supplements containing ephedrine alkaloids are banned in the United States.
Original reports cannot give an individual probability
An FDA-report analysis described serious cardiovascular and CNS events. These selected reports do not show how frequently harm occurs or establish an interaction with aripiprazole lauroxil.
An injection does not make an energy product protective
ARISTADA is a long-acting antipsychotic treatment for schizophrenia. There is no evidence here that it prevents ephedra toxicity or that ephedra safely offsets tiredness.
Bring the product to the treating team
Tell the clinician about the ingredients and any recent use. Chest pain, severe agitation, seizures or collapse need urgent assessment; do not alter the injection schedule yourself.
Evidence and practical considerations
Side effects & toxicity
Exact-pair risk remains insufficiently established; standalone ephedra hazards support avoiding unsupervised use.
- Exact scope
- Ephedra sinica and ephedrine-alkaloid-containing products; amount and other stimulant ingredients matter. with Exact aripiprazole lauroxil long-acting intramuscular suspension. Exact RxNorm IN1673265, ester prodrug, not oral aripiprazole. ARISTADA maintenance injection and ARISTADA INITIO initiation product distinguished; oral aripiprazole clinical findings require explicit active-metabolite bridge.
- Medication form and route
- intramuscular
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact injected-prodrug co-use study or quantified interaction; report series lacks an exposure denominator.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed aripiprazole lauroxil.
Prodrug hydrolyzed to active aripiprazole; long-acting injection, cognitive/motor and orthostatic precautions; duration-dependent CYP3A4 inducer instructions.
How this applies: Exact RxNorm IN1673265, ester prodrug, not oral aripiprazole. ARISTADA maintenance injection and ARISTADA INITIO initiation product distinguished; oral aripiprazole clinical findings require explicit active-metabolite bridge.
No supplement-specific event rate, universal timing rule or untested route/preparation equivalence.
Source 2: official botanical guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering Ephedra sinica products.
Serious cardiovascular and psychiatric adverse effects reported, including with low-dose or short-term exposure; US ephedrine-alkaloid dietary supplements banned.
How this applies: Standalone supplement safety concern, not proven pair-specific antagonism.
Not an aripiprazole lauroxil co-use study or a population-specific incidence estimate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 140 adverse-event reports submitted to FDA.
Reports judged related or possibly related included cardiovascular and CNS events, some fatal or disabling.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
Selected reports without an exposed-user denominator cannot establish frequency; no aripiprazole lauroxil coexposure.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: 32b03c96a0715afd
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.